166 related articles for article (PubMed ID: 27381617)
1. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery.
Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V
In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
[TBL] [Abstract][Full Text] [Related]
3. Detection of extra-regional tumour recurrence with
Brar H; May T; Tau N; Langer D; MacCrostie P; Han K; Metser U
Clin Radiol; 2017 Apr; 72(4):302-306. PubMed ID: 28108013
[TBL] [Abstract][Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
5. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.
Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S
J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
[TBL] [Abstract][Full Text] [Related]
7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
8. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis.
Travers S; Joshi K; Miller DC; Singh A; Nada A; Biedermann G; Cousins JP; Litofsky NS
World Neurosurg; 2021 Jul; 151():e1059-e1068. PubMed ID: 34052453
[TBL] [Abstract][Full Text] [Related]
9. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
11. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
[TBL] [Abstract][Full Text] [Related]
12. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
13. Determination of brain tumor recurrence using
Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T
Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Gwak HS; Youn SM; Chang U; Lee DH; Cheon GJ; Rhee CH; Kim K; Kim HJ
Minim Invasive Neurosurg; 2006 Jun; 49(3):127-34. PubMed ID: 16921451
[TBL] [Abstract][Full Text] [Related]
15. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
16. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Chao ST; Suh JH; Raja S; Lee SY; Barnett G
Int J Cancer; 2001 Jun; 96(3):191-7. PubMed ID: 11410888
[TBL] [Abstract][Full Text] [Related]
17. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J
Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
[TBL] [Abstract][Full Text] [Related]
19. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
Chen YR; Li WX; Lin YR; Chen LH
Ai Zheng; 2004 Oct; 23(10):1210-2. PubMed ID: 15473938
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
